NATCO PHARMA LTD.Viés de alta
Natco Pharma Ltd
Atualizado
TARGET AND SL @760
FUNDAMENTALS
Market Cap
₹ 14,846 Cr.
Current Price
₹ 829
High / Low
₹ 928 / 502
Stock P/E
13.2
Book Value
₹ 296
Dividend Yield
1.00 %
ROCE
17.7 %
ROE
15.3 %
Face Value
₹ 2.00
Promoter holding
49.7 %
EPS last year
₹ 39.2
EPS latest quarter
₹ 20.6
Debt
₹ 248 Cr.
Pledged percentage
0.00 %
Net CF
₹ 20.8 Cr.
Price to Cash Flow
17.5
Free Cash Flow
₹ 674 Cr.
Debt to equity
0.05
OPM last year
34.6 %
OPM 5Year
29.7 %
Reserves
₹ 5,258 Cr.
Price to book value
2.80
Int Coverage
91.3
PEG Ratio
33.8
Price to Sales
4.17
Sales growth 3Years
12.2 %
Return on assets
13.0 %
FUNDAMENTALS
Market Cap
₹ 14,846 Cr.
Current Price
₹ 829
High / Low
₹ 928 / 502
Stock P/E
13.2
Book Value
₹ 296
Dividend Yield
1.00 %
ROCE
17.7 %
ROE
15.3 %
Face Value
₹ 2.00
Promoter holding
49.7 %
EPS last year
₹ 39.2
EPS latest quarter
₹ 20.6
Debt
₹ 248 Cr.
Pledged percentage
0.00 %
Net CF
₹ 20.8 Cr.
Price to Cash Flow
17.5
Free Cash Flow
₹ 674 Cr.
Debt to equity
0.05
OPM last year
34.6 %
OPM 5Year
29.7 %
Reserves
₹ 5,258 Cr.
Price to book value
2.80
Int Coverage
91.3
PEG Ratio
33.8
Price to Sales
4.17
Sales growth 3Years
12.2 %
Return on assets
13.0 %
Trade ativo
Trade ativo
Aviso legal
As informações e publicações não devem ser e não constituem conselhos ou recomendações financeiras, de investimento, de negociação ou de qualquer outro tipo, fornecidas ou endossadas pela TradingView. Leia mais em Termos de uso.